Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)(†)

BACKGROUND: There is no standard first-line chemotherapy for advanced urothelial carcinoma (aUC) in cisplatin-ineligible (cisplatin-unfit) patients. The study assessed the efficacy and tolerability profile of two vinflunine-based cytotoxic regimens in this setting. PATIENTS AND METHODS: Patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W.-C., Albiges, L., Lin, C.-C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N., Culine, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769994/
https://www.ncbi.nlm.nih.gov/pubmed/26673352
http://dx.doi.org/10.1093/annonc/mdv609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769994/
https://www.ncbi.nlm.nih.gov/pubmed/26673352
http://dx.doi.org/10.1093/annonc/mdv609

Ejemplares similares